Q & M Dental Group (Singapore) (QC7) H1 2026 earnings summary

Executive summary

• Revenue rose 13% year-over-year to $99.5 million in 1H26, driven by core dental business growth and consolidation of Aoxin Q & M as a subsidiary.

• Net profit after tax increased 27% to $5.1 million, with profit attributable to owners up to $4.9 million.

• EBITDA grew 19% to $19.2 million, and basic EPS improved to 0.52 cents from 0.41 cents.

• Cash and cash equivalents stood at $119.2 million as of 30 June 2026.

• The Group expanded its network to 113 dental outlets in Singapore and 36 in Malaysia, and continued regional expansion.

Financial highlights

• Core dental business revenue increased 13% to $98.6 million; other businesses revenue fell 22% to $0.9 million due to clinic closures.

• Cost of sales for core dental business rose 37% to $13.2 million; employee benefits expense up 16% to $59.9 million.

• Depreciation and amortisation expense increased 28% to $3.2 million; finance costs up 57% to $3.7 million due to MTN issuance.

• Net other gains of $0.9 million, mainly from property disposal.

• Interim dividend maintained at 0.40 cent per share.

Outlook and guidance

• Focus remains on integrating new acquisitions in Australia and Thailand, with an emphasis on operational efficiency and sustainable growth.

• No significant changes in industry trends or competitive conditions expected in the next 12 months.

• Ongoing expansion of Singapore clinic network through organic growth and value-accretive acquisitions.